Literature DB >> 21515266

Why is PTPN22 a good candidate susceptibility gene for autoimmune disease?

Garth L Burn1, Lena Svensson, Cristina Sanchez-Blanco, Manoj Saini, Andrew P Cope.   

Abstract

The PTPN22 locus is one of the strongest risk factors outside of the major histocompatability complex that associates with autoimmune diseases. PTPN22 encodes lymphoid protein tyrosine phosphatase (Lyp) which is expressed exclusively in immune cells. A single base change in the coding region of this gene resulting in an arginine to tryptophan amino acid substitution within a polyproline binding motif associates with type 1 diabetes, rheumatoid arthritis, systemic lupus erythematosis, Hashimotos thyroiditis, Graves disease, Addison's disease, Myasthenia Gravis, vitiligo, systemic sclerosis juvenile idiopathic arthritis and psoriatic arthritis. Here, we review the current understanding of the PTPN22 locus from a genetic, geographical, biochemical and functional perspective.
Copyright © 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21515266     DOI: 10.1016/j.febslet.2011.04.032

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  90 in total

Review 1.  Negative regulation of TLR signaling in myeloid cells--implications for autoimmune diseases.

Authors:  Jessica A Hamerman; Jessica Pottle; Minjian Ni; Yantao He; Zhong-Yin Zhang; Jane H Buckner
Journal:  Immunol Rev       Date:  2016-01       Impact factor: 12.988

Review 2.  Candidate genes expressed in human islets and their role in the pathogenesis of type 1 diabetes.

Authors:  Joachim Storling; Caroline Anna Brorsson
Journal:  Curr Diab Rep       Date:  2013-10       Impact factor: 4.810

Review 3.  Influence of type 1 diabetes genes on disease progression: similarities and differences between countries.

Authors:  Johanna Lempainen; Jorma Ilonen
Journal:  Curr Diab Rep       Date:  2012-10       Impact factor: 4.810

4.  Genetic link of type 1 diabetes susceptibility loci with rheumatoid arthritis in Pakistani patients.

Authors:  Aysha Karim Kiani; Sidrah Jahangir; Sidrah Jahngir; Peter John; Attya Bhatti; Asima Zia; Xingbin Wang; F Yesim Demirci; M Ilyas Kamboh
Journal:  Immunogenetics       Date:  2015-04-24       Impact factor: 2.846

5.  Role of the C1858T polymorphism of protein tyrosine phosphatase non-receptor type 22 (PTPN22) in children and adolescents with type 1 diabetes.

Authors:  A Blasetti; C Di Giulio; S Tumini; M Provenzano; D Rapino; L Comegna; G Prezioso; R Chiuri; S Franchini; F Chiarelli; L Stuppia
Journal:  Pharmacogenomics J       Date:  2016-02-23       Impact factor: 3.550

Review 6.  Thymic Germinal Centers and Corticosteroids in Myasthenia Gravis: an Immunopathological Study in 1035 Cases and a Critical Review.

Authors:  Frédérique Truffault; Vincent de Montpreville; Bruno Eymard; Tarek Sharshar; Rozen Le Panse; Sonia Berrih-Aknin
Journal:  Clin Rev Allergy Immunol       Date:  2017-02       Impact factor: 8.667

Review 7.  Negative regulators and their mechanisms in NLRP3 inflammasome activation and signaling.

Authors:  Jin Kyung Kim; Hyo Sun Jin; Hyun-Woo Suh; Eun-Kyeong Jo
Journal:  Immunol Cell Biol       Date:  2017-03-30       Impact factor: 5.126

8.  PTPN22 gene functional polymorphism (rs2476601) in older adults with frailty syndrome.

Authors:  Rubén Rabaneda-Bueno; Norma Torres-Carrillo; José Alberto Ávila-Funes; Luis Miguel Gutiérrez-Robledo; Thalía Gabriela Pérez-Suárez; José Luis Acosta; Sara Torres-Castro; Ana Lilia Fletes-Rayas; Itzae Gutierrez-Hurtado; Elena Sandoval-Pinto; Rosa Cremades; Nora Magdalena Torres-Carrillo
Journal:  Mol Biol Rep       Date:  2021-02-21       Impact factor: 2.316

Review 9.  Mechanisms of autoimmune thyroid diseases: from genetics to epigenetics.

Authors:  Yaron Tomer
Journal:  Annu Rev Pathol       Date:  2014       Impact factor: 23.472

10.  The functional PTPN22 C1858T polymorphism confers risk for rheumatoid arthritis in patients from Central Mexico.

Authors:  J F Mendoza Rincón; D López Cano; S Jiménez Morales; M L Rivas Jiménez; R E Barbosa Cobos; J Ramírez Bello
Journal:  Clin Rheumatol       Date:  2016-03-07       Impact factor: 2.980

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.